Evidence map›Paper›PMID 40210660›Full record

ArticleNature communications2025

Characterization of dsRNA binding proteins through solubility analysis identifies ZNF385A as a dsRNA homeostasis regulator.

Na Jiang, Hekun Yang, Yi Lei, Weida Qin, Huifang Xiong, Kuan Chen, Kunrong Mei, Gongyu Li, Xin Mu, Ruibing Chen

Abstract read
In one paragraph

Article in Nature communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Na JiangSchool of Pharmaceutical Science and Technology, Faculty of Medicine, Tianjin University, Tianjin, China.
Hekun YangSchool of Pharmaceutical Science and Technology, Faculty of Medicine, Tianjin University, Tianjin, China.
Yi LeiSchool of Pharmaceutical Science and Technology, Faculty of Medicine, Tianjin University, Tianjin, China.
Weida QinTianjin Key Laboratory of Biosensing and Molecular Recognition, Research Center for Analytical Science, Frontiers Science Center for New Organic Matter, College of Chemistry, Nankai University, Tianjin, China.
Huifang XiongSchool of Pharmaceutical Science and Technology, Faculty of Medicine, Tianjin University, Tianjin, China.
Kuan ChenSchool of Pharmaceutical Science and Technology, Faculty of Medicine, Tianjin University, Tianjin, China.
Kunrong MeiSchool of Pharmaceutical Science and Technology, Faculty of Medicine, Tianjin University, Tianjin, China.ORCID http://orcid.org/0000-0001-7827-2944
Gongyu LiTianjin Key Laboratory of Biosensing and Molecular Recognition, Research Center for Analytical Science, Frontiers Science Center for New Organic Matter, College of Chemistry, Nankai University, Tianjin, China.ORCID http://orcid.org/0000-0002-2367-4433
Xin MuSchool of Pharmaceutical Science and Technology, Faculty of Medicine, Tianjin University, Tianjin, China. xin_mu@tju.edu.cn.
Ruibing ChenSchool of Pharmaceutical Science and Technology, Faculty of Medicine, Tianjin University, Tianjin, China. rbchen@tju.edu.cn.ORCID http://orcid.org/0000-0002-1149-8049

Funding

National Natural Science Foundation of China (National Science Foundation of China) 22474087, 92354303, 22293030, 22293032
6 · The paper itself

Abstract

Double-stranded RNA (dsRNA) binding proteins (dsRBPs) play crucial roles in various cellular processes, especially in the innate immune response. Comprehensive characterization of dsRBPs is essential to understand the intricate mechanisms for dsRNA sensing and response. Traditional methods have predominantly relied on affinity purification, favoring the isolation of strong dsRNA binders. Here, we adopt the proteome integral solubility alteration (PISA) workflow for characterizing dsRBPs, resulting in the observation of 18 known dsRBPs and the identification of 200 potential dsRBPs. Next, we focus on zinc finger protein 385 A (ZNF385A) and discover that its knockout activates the transcription of interferon-β in the absence of immunogenic stimuli. The knockout of ZNF385A elevates the level of endogenous dsRNAs, especially transcripts associated with retroelements, such as short interspersed nuclear element (SINE), long interspersed nuclear element (LINE), and long terminal repeat (LTR). Moreover, loss of ZNF385A enhances the bioactivity of 5-Aza-2'-deoxycytidine (5-AZA-CdR) and tumor-killing effect of NK cells. Our findings greatly expand the dsRBP reservoir and contribute to the understanding of cellular dsRNA homeostasis.

Indexed as

HomeostasisRNA-Binding ProteinsRNA, Double-StrandedAnimalsDecitabineHEK293 CellsHumansImmunity, InnateInterferon-betaMiceSolubilityDecitabineInterferon-betaRNA-Binding ProteinsRNA, Double-Stranded

Identifiers

PMID40210660
PMCPMC11985509

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.